ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
21 announcements
Balaji Phosphates received shareholder approval to issue 25,00,000 convertible warrants worth ₹23.45 Crore and 14,49,900 equity shares for a business acquisition via preferential issue.
Balaji Phosphates' shareholders approved the issuance of 5,146,350 convertible warrants and 1,449,900 equity shares to promoters and other investors at the 30th AGM.
Balaji Phosphates Limited issued a corrigendum to its 30th Annual General Meeting notice. The amendment provides revisions to the proposed preferential share allotment for business acquisition.
Balaji Phosphates Limited replaced an allottee for its proposed 25 lakh warrant issuance. The board also approved a corrigendum to its AGM notice per NSE observations.
Balaji Phosphates Limited scheduled a board meeting for September 18, 2026, to discuss fund raising via preferential issue.
Balaji Phosphates Limited has submitted its Annual Report for the financial year 2025-26, which includes the notice for its 30th Annual General Meeting.
Balaji Phosphates issued notice for its Annual General Meeting scheduled on September 26, 2026, to consider financial statements, capital raising, and various related-party transactions.
Balaji Phosphates' board approved acquiring Chatak Agro and Divya Jyoti Agritech, and authorized a preferential issue of warrants to promoters and promoter group entities.
Balaji Phosphates Limited has scheduled a board meeting for August 27, 2026, to consider fund raising via a preferential issue. The company has closed its trading window accordingly.
Balaji Phosphates cancelled its proposed Extra-Ordinary General Meeting. The company will now include these agenda items in the upcoming Annual General Meeting notice.
Balaji Phosphates clarified that its IPO utilization certificate was omitted due to human error. The company submitted the missing auditor's report to resolve NSE's query.
Balaji Phosphates appointed Shubham Jain as Internal Auditor and re-appointed M P Turakhia & Associates as Cost Auditors. Both appointments are for a twelve-month term.
Balaji Phosphates approved a Rs.24.575 Crore preferential warrant issue to non-promoters. It also proposed acquiring group companies via share swaps to consolidate business operations.
Balaji Phosphates Limited cancelled its board meeting scheduled for 1 July 2026. The agenda included fund raising, capital increase and other business.
Balaji Phosphates Limited reported nil deviation in the utilisation of ₹41.58 Crore raised through its IPO. Unutilised funds are temporarily invested in Axis Bank term deposits.
Balaji Phosphates Ltd reported revenue from operations of ₹85.8 Cr (+33.9% YoY) and net profit of ₹2.2 Cr (-38.9% YoY) for H2 FY26.
Balaji Phosphates Limited reported audited annual financial results for the period ended March 31, 2026. The board approved standalone and consolidated statements, showing significant operational performance.
Balaji Phosphates Limited scheduled a board meeting for May 29, 2026, to approve audited annual financial results. The trading window remains closed for designated persons.
Balaji Phosphates Limited submitted a compliance report under Regulation 57(5) for the quarter ended March 31, 2026. The company confirmed it has no outstanding non-convertible securities for which interest, dividend, or principal payments were due during the period.
Balaji Phosphates Limited has certified its eligibility for compliance exemptions under SEBI Regulations. Having listed on the NSE Emerge SME platform on March 07, 2025, the company is exempt from submitting the Annual Secretarial Compliance Report for the financial year 2025-2026.
Balaji Phosphates Limited has filed an intimation regarding its eligibility for exemptions from certain SEBI corporate governance regulations. As an SME-listed entity on the NSE Emerge platform, it qualifies for exemptions under Regulation 15(2)(b). The company remains committed to voluntary compliance with good corporate governance standards.